Effect of TPOAb, HbA1c, PLGF and lipid level on pregnancy outcome in pregnant women with gestational diabetes mellitus

doi:10.3969/j.issn.1004-583X.2021.01.011

Abstract

Abstract:

Objective To investigate the levels and significance of antithyroid peroxidase antibody(TPOAb), hemoglobin A1c(HbA₁c), placental growth factor(PLGF) and blood lipid in pregnant women with gestational diabetes mellitus(GDM). Methods A total of 180 GDM patients in Nanjing Maternity and Child Health Care Hospital were selected as observation group. A total of 180 healthy pregnant women who were examined in the above hospital during the same period were selected as control group. Fasting venous blood was collected at 24-27 weeks of gestation, and TPOAb, HbA₁c PLGF and lipid indexes were detected and compared between two groups. The pregnancy outcomes of GDM patients were recorded, and TPOAb, HbA₁c, PLGF and blood lipid indexes between patients with poor pregnancy outcomes and those with normal pregnancy outcomes were analyzed. Results TPOAb, HbA₁c, TG in observation group were higher than those in control group, while PLGF was lower than that in control group (P<0.05); TPOAb positive rate in observation group was higher than that in control group (χ²=12.394, P<0.01); there were 56 patients(31.11%) with poor pregnancy outcomes and 124 patients(68.89%) with normal pregnancy outcomes in observation group. TPOAb, HbA₁c, TG in patients with poor pregnancy outcome were higher than those in patients with normal pregnancy outcome, while PLGF was lower than that in patients with normal pregnancy outcome (P<0.05); TPOAb positive rate of patients with poor pregnancy outcome was higher than that of normal pregnancy outcome (χ²=5.762, P=0.016).Conclusion There were significant differences in TPOAb, HbA₁c, PLGF and TG between GDM pregnant women and healthy pregnant women, which may have some adverse influence on pregnancy outcomes.

Key words: diabetes, gestational, peroxidases, hemoglobins, glycosylated, intercellular signaling peptides and proteins, dyslipidemia, pregnancy outcome

CLC Number:

R587.1

You Mu, Cai Manhong. Effect of TPOAb, HbA₁c, PLGF and lipid level on pregnancy outcome in pregnant women with gestational diabetes mellitus[J]. Clinical Focus, 2021, 36(1): 54-57.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.01.011

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I1/54

Figures/Tables 5

References 20

[1]	Aydin H, Çelik Ö, Yazici D, et al. Prevalence and predictors of gestational diabetes mellitus:a nationwide multicentre prospective study[J]. Diabet Med, 2018,35(8):90-95.
[2]	柯晓琼, 夏小文, 张祖艳等. 妊娠中、晚期筛查HbA₁c预测妊娠期糖尿病及妊娠结局[J]. 中国计划生育学杂志, 2020,28(2):277-279, 283.
[3]	张淳义, 倪颖华, 季鑫等. 妊娠期糖尿病患者糖化血红蛋白和糖化白蛋白水平与新生儿体重的相关性[J]. 检验医学, 2017,32(3):165-168.
[4]	陆勤. 妊娠期糖尿病孕妇甲状腺功能指标与妊娠结局[J]. 中国计划生育学杂志, 2019,27(9):1208-1211.
[5]	徐霞, 尤子善. 妊娠期糖尿病高危孕妇血清中T3、T4、FT3、FT4、TSH、TPOAb及TGAb含量变化分析[J]. 临床和实验医学杂志, 2017,16(24):2463-2466.
[6]	高翠玲, 陈井丽. 维生素D和PLGF在妊娠期糖尿病患者中的表达及对妊娠结局及新生儿的影响[J]. 中国计划生育学杂志, 2020,28(4):496-499.
[7]	邱情, 韩亚娟, 沈洁等. 妊娠期糖尿病与妊娠期甲状腺功能状态的相关性分析[J]. 中国糖尿病杂志, 2017,25(4):308-311.
[8]	陈贤坤, 吕嘉敏, 陈映慧等. 妊娠期糖尿病妇女妊娠早期TPOAb状态与甲状腺功能紊乱的关系[J]. 海南医学, 2019,30(9):1140-1143.
[9]	丁春学, 马一鸣. TPOAb、TSH水平对妊娠期糖尿病、高血压及妊娠结局的影响[J]. 河北医药, 2019,41(9):1321-1324.
[10]	Kostecka-Matyja M, Fedorowicz A, Bar-Andziak E, et al. Reference values for TSH and free thyroid hormones in healthy pregnant women in Poland: A prospective, multicenter study[J]. Eur Thyroid J, 2017,6(2):82-88. doi: 10.1159/000453061 pmid: 28589089
[11]	Promberger R, Walch K, Seemann R, et al. A retrospective study on the association between thyroid autoantibodies with β2-glycoprotein and cardiolipin antibodies in recurrent miscarriage[J]. Iran J Allergy Asthma Immunol, 2017,16(1):72-76.
[12]	李春莉, 余浪, 李秋红等. 妊娠早期单纯低甲状腺素血症与妊娠期糖尿病相关性分析[J]. 中华内分泌代谢杂志, 2017,33(3):194-197.
[13]	吴红丽, 孙健, 孙冀兵, 等. 孕早期糖化血红蛋白水平检查在诊断妊娠期糖尿病中的效果评价[J]. 中国实验诊断学, 2017,21(3):455-458.
[14]	张星磊, 王敬华. 血清胎盘生长因子联合其他血清学检测指标在孕早期唐氏筛查中应用初探[J]. 中国计划生育学杂志, 2019,27(6):780-782.
[15]	蔡莉娜, 刘剑波, 吴树彪等. 可溶性血管内皮生长因子受体-1/胎盘生长因子与子宫动脉搏动指数联合预测子痫前期的临床价值研究[J]. 中国全科医学, 2018,21(7):827-830.
[16]	Brand JS, West J, Tuffnell D, et al. Gestational diabetes and ultrasound-assessed fetal growth in South Asian and White European women:findings from a prospective pregnancy cohort[J]. BMC Med, 2018,16(1):103-106. doi: 10.1186/s12916-018-1096-5 URL
[17]	史亚波, 任亚楠, 万惠丽等. 胎盘生长因子在妊娠期糖尿病患者胎盘中抑制滋养细胞凋亡的作用研究[J]. 实用妇产科杂志, 2019,35(1):39-44.
[18]	Ghodke B, Pusukum R, Mehta V. Assoeiation of lipid profile in pregnancy with preeclampsia,gestational diabetes mellitus,and preterm delivery[J]. Cureus, 2017,9(7):e1420-1425.
[19]	Oostvogels A, Bussehers WB, Spierings EJM, et al. Pre-pregnancy weight status,early pregnancy lipid profile and blood pressure course during pregnancy:The ABCD study[J]. PLoS One, 2017,12(5):e0177554. doi: 10.1371/journal.pone.0177554 URL
[20]	龙宇航, 邓琅辉, 刘斌, 等. 影响妊娠中晚期血脂水平的相关因素及其与妊娠期糖尿病发病的关系[J]. 中山大学学报(医学科学版), 2018,39(5):742-747.

组别	例数	年龄(岁)	孕次	产次	孕前BMI	分娩孕周
观察组	180	26.93±3.89	1.73±0.38	1.51±0.27	22.48±1.33	37.89±2.52
对照组	180	26.48±3.75	1.79±0.32	1.47±0.31	22.65±1.21	38.14±2.68
t值		1.117	1.620	1.305	1.268	0.912
P值		0.265	0.106	0.193	0.205	0.363

组别	例数	年龄(岁)	孕次	产次	孕前BMI	分娩孕周
观察组	180	26.93±3.89	1.73±0.38	1.51±0.27	22.48±1.33	37.89±2.52
对照组	180	26.48±3.75	1.79±0.32	1.47±0.31	22.65±1.21	38.14±2.68
t值		1.117	1.620	1.305	1.268	0.912
P值		0.265	0.106	0.193	0.205	0.363

组别		例数		TPOAb(U/ml)		HbA₁c(%)		PLGF(pg/ml)		TG(mmol/L)		TC(mmol/L)
观察组		180		43.66±11.36		5.57±0.63		69.68±19.74		2.31±0.64		6.05±0.66
对照组		180		18.78±7.13		5.03±0.67		128.24±25.83		1.98±0.68		5.93±0.71
t值				24.888		7.878		24.167		4.741		1.661
P值				<0.01		<0.01		<0.01		<0.01		0.098
组别	例数		HDL-C(mmol/L)		LDL-C(mmol/L)		Apo A1(g/L)		Apo B(g/L)		Apo E(mg/L)		Lp(a) (mg/L)
观察组	180		1.93±0.57		3.41±0.75		2.11±0.57		1.04±0.43		47.23±5.36		223.62±27.28
对照组	180		1.88±0.68		3.35±0.70		2.04±0.53		0.97±0.51		46.28±4.89		219.93±23.56
t值			0.756		0.785		1.207		1.408		1.757		1.373
P值			0.450		0.433		0.228		0.160		0.080		0.170

组别		例数		TPOAb(U/ml)		HbA₁c(%)		PLGF(pg/ml)		TG(mmol/L)		TC(mmol/L)
观察组		180		43.66±11.36		5.57±0.63		69.68±19.74		2.31±0.64		6.05±0.66
对照组		180		18.78±7.13		5.03±0.67		128.24±25.83		1.98±0.68		5.93±0.71
t值				24.888		7.878		24.167		4.741		1.661
P值				<0.01		<0.01		<0.01		<0.01		0.098
组别	例数		HDL-C(mmol/L)		LDL-C(mmol/L)		Apo A1(g/L)		Apo B(g/L)		Apo E(mg/L)		Lp(a) (mg/L)
观察组	180		1.93±0.57		3.41±0.75		2.11±0.57		1.04±0.43		47.23±5.36		223.62±27.28
对照组	180		1.88±0.68		3.35±0.70		2.04±0.53		0.97±0.51		46.28±4.89		219.93±23.56
t值			0.756		0.785		1.207		1.408		1.757		1.373
P值			0.450		0.433		0.228		0.160		0.080		0.170

组别		例数		TPOAb(U/ml)		HbA₁c(%)		PLGF(pg/ml)		TG(mmol/L)		TC(mmol/L)
不良		56		64.22±12.14		6.23±0.58		58.14±19.66		2.69±0.69		6.07±0.69
正常		124		33.83±9.64		5.29±0.61		74.43±22.15		2.14±0.72		5.98±0.68
t值				17.885		9.613		4.672		4.755		0.179
P值				<0.01		<0.01		<0.01		<0.01		0.858
组别	例数		HDL-C(mmol/L)		LDL-C(mmol/L)		Apo A1(g/L)		Apo B(g/L)		Apo E(mg/L)		Lp(a) (mg/L)
不良	56		1.96±0.61		3.47±0.79		2.24±0.63		1.10±0.48		47.64±5.69		228.35±28.53
正常	124		1.89±0.64		3.36±0.81		2.09±0.64		0.98±0.52		47.03±5.84		220.47±29.04
t值			0.682		0.841		1.448		1.451		0.647		1.677
P值			0.496		0.401		0.149		0.186		0.518		0.095

Effect of TPOAb, HbA₁c, PLGF and lipid level on pregnancy outcome in pregnant women with gestational diabetes mellitus

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 20

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Lv Shasha, Song Jinlan, Shi Jian. Mitochondrial mutation m.3243A> G associated with diabetes mellitus: One case report and literature review [J]. Clinical Focus, 2024, 39(2): 160-163.
[2]	Zhang Jianan, Sun Linlin, Zhan Xiaoyan, Li Bing. Correlation between serum Vitamin B₁₂ and mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(1): 34-37.
[3]	Wei Zeng, Cao Ling, She Dunmin, Liu Yan, Wang Yan, Zhang Zhenwen. The causes of death in 54 patients with type 2 diabetes mellitus complicated with COVID-19 [J]. Clinical Focus, 2023, 38(9): 806-812.
[4]	Yang Xin, Xu Huajiao. Bibliometric analysis of literatures reporting psychological intervention of patients with diabetes mellitus: Based on Web of Science [J]. Clinical Focus, 2023, 38(8): 731-736.
[5]	Jin Jiahui, Yang Yang, Qin Tong, He Yuxin, Su Meihua. Probiotic supplementation on improving glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(7): 581-587.
[6]	Wu Yanan, Yan Tianmei, Liang Peng, Wei Limin. High-risk identification of depressive symptoms in middle-elderly patients with diabetes [J]. Clinical Focus, 2023, 38(6): 516-520.
[7]	Yang Minxing, Sun Lu, Ye Yun, Xu Wendong, Huang Xiaolin, Zhang Haiyun, Xu Yinglei. Characteristics of cognitive function and corresponding factors in young and middle-aged patients with type 2 diabetes with obstructive sleep apnea hypopnea syndrome [J]. Clinical Focus, 2023, 38(3): 216-220.
[8]	Han Tuo, Wang Lixia, Wang Yiwen, Li Ying, Gong Hong, Zhang Chunyan, Zhang Yan, Li Yongqin, Wang Congxia. Correlation analysis between dietary nutrient intake with blood glucose and insulin resistance in healthy population [J]. Clinical Focus, 2023, 38(2): 126-131.
[9]	Rao Xiaojuan, Shi Shuangwei, Sang Yanhong. Comparison of short-term efficacy of insulin degludec/insulin versus continuous subcutaneous infusion of insulin asparton diabetic patients admitted in non-endocrinology departments [J]. Clinical Focus, 2023, 38(2): 132-136.
[10]	Li Huifang, Miao Xia. Prediction of thyroid hormone level on risk of type 2 diabetes nephropathy [J]. Clinical Focus, 2023, 38(2): 137-142.
[11]	Liao Kunfeng, Yao Yisong, Yang Jinpan, Yang Xining, Li Yaru, Zhou Hongyan, Liang Piao. Status and influencing factors of fear of progression in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(12): 1095-1100.
[12]	Jiang Ji, Zhu Xiaogang, Jiang Shan, Dawa Zhaba, Cen Qiang. Risk factors of proteinuria in hypertensive people living at high altitude for generations [J]. Clinical Focus, 2023, 38(12): 1086-1090.
[13]	Zhu Chenglou, Wu Qiong, Da Mingxu. Risk assessment of pancreatic cancer in patients with type 2 diabetes mellitus treated with sitagliptin: A meta-analysis of randomized controlled trials [J]. Clinical Focus, 2023, 38(12): 1061-1066.
[14]	Shi Peihua, Lin Yanlin, Bi Lifang. Study on the correlation of NLR, PLR and MLR with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2023, 38(11): 996-1001.
[15]	Xu Yang, Xue Ling. Influencing factors for mild cognitive impairment in type H hypertension patients combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(10): 887-892.